HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

capecitabine-irinotecan combination

a phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer 5/2007
Also Known As:
bXELIRI
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Sur, H Y: 1 article (05/2007)
2. Choi, I K: 1 article (05/2007)
3. Kim, Y H: 1 article (05/2007)
4. Chun, H J: 1 article (05/2007)
5. Oh, S C: 1 article (05/2007)
6. Seo, J H: 1 article (05/2007)
7. Mok, Y J: 1 article (05/2007)
8. Park, S S: 1 article (05/2007)
9. Shin, S W: 1 article (05/2007)
10. Kim, J S: 1 article (05/2007)

Related Diseases

1. Stomach Neoplasms (Stomach Cancer)
2. Colorectal Neoplasms (Colorectal Cancer)

Related Drugs and Biologics

1. capecitabine (Xeloda)
2. irinotecan (Camptosar)